BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 19556287)

  • 21. No evidence of RET germline mutations in familial pituitary adenoma.
    Heliövaara E; Tuupanen S; Ahlsten M; Hodgson S; de Menis E; Kuismin O; Izatt L; McKinlay Gardner RJ; Gundogdu S; Lucassen A; Arola J; Tuomisto A; Mäkinen M; Karhu A; Aaltonen LA
    J Mol Endocrinol; 2011 Feb; 46(1):1-8. PubMed ID: 20956458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of neurogenins and NeuroD1 in human pituitary tumours.
    Fratticci A; Grieco FA; Spilioti C; Giangaspero F; Ventura L; Esposito V; Piccirilli M; Santoro A; Gulino A; Cantore G; Alesse E; Jaffrain-Rea ML
    J Endocrinol; 2007 Sep; 194(3):475-84. PubMed ID: 17761887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial pituitary adenomas - who should be tested for AIP mutations?
    Korbonits M; Storr H; Kumar AV
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):351-6. PubMed ID: 22612670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
    Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of AIP-related molecules in elucidation of cellular pathways in pituitary adenomas.
    Heliövaara E; Raitila A; Launonen V; Paetau A; Arola J; Lehtonen H; Sane T; Weil RJ; Vierimaa O; Salmela P; Tuppurainen K; Mäkinen M; Aaltonen LA; Karhu A
    Am J Pathol; 2009 Dec; 175(6):2501-7. PubMed ID: 19850893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene.
    Naves LA; Daly AF; Vanbellinghen JF; Casulari LA; Spilioti C; Magalhães AV; Azevedo MF; Giacomini LA; Nascimento PP; Nunes RO; Rosa JW; Jaffrain-Rea ML; Bours V; Beckers A
    Eur J Endocrinol; 2007 Oct; 157(4):383-91. PubMed ID: 17893251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) in Non-Somatotroph Pituitary Tumours and the Effects of PPARα Agonists on MMQ Cells.
    Polidoro MA; Rotondi S; Morace R; Rostomyan L; Colapietro A; Arcella A; Ventura L; Angelucci A; Giangaspero F; Esposito V; Beckers A; Jaffrain-Rea ML
    Horm Metab Res; 2018 Aug; 50(8):640-647. PubMed ID: 30021235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of neuro D1 in human normal pituitaries and pituitary adenomas.
    Oyama K; Sanno N; Teramoto A; Osamura RY
    Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic, molecular and clinical features of familial isolated pituitary adenomas.
    Daly AF; Tichomirowa MA; Beckers A
    Horm Res; 2009 Apr; 71 Suppl 2():116-22. PubMed ID: 19407507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas.
    Barlier A; Vanbellinghen JF; Daly AF; Silvy M; Jaffrain-Rea ML; Trouillas J; Tamagno G; Cazabat L; Bours V; Brue T; Enjalbert A; Beckers A
    J Clin Endocrinol Metab; 2007 May; 92(5):1952-5. PubMed ID: 17299063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
    Beckers A; Aaltonen LA; Daly AF; Karhu A
    Endocr Rev; 2013 Apr; 34(2):239-77. PubMed ID: 23371967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aryl hydrocarbon receptor (AHR) is a potential tumour suppressor in pituitary adenomas.
    Formosa R; Borg J; Vassallo J
    Endocr Relat Cancer; 2017 Aug; 24(8):445-457. PubMed ID: 28649092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
    Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide scan identifies novel modifier loci of acromegalic phenotypes for isolated familial somatotropinoma.
    Khoo SK; Pendek R; Nickolov R; Luccio-Camelo DC; Newton TL; Massie A; Petillo D; Menon J; Cameron D; Teh BT; Chan SP
    Endocr Relat Cancer; 2009 Sep; 16(3):1057-63. PubMed ID: 19443539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Aryl hydrocarbon receptor interacting protein gene and familial isolated pituitary adenomas].
    Cai F; Zhang YD; Dai CX; Liu XH; Yang YK; Yao Y; Wang RZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):640-4. PubMed ID: 23286415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.
    Cuny T; Pertuit M; Sahnoun-Fathallah M; Daly A; Occhi G; Odou MF; Tabarin A; Nunes ML; Delemer B; Rohmer V; Desailloud R; Kerlan V; Chabre O; Sadoul JL; Cogne M; Caron P; Cortet-Rudelli C; Lienhardt A; Raingeard I; Guedj AM; Brue T; Beckers A; Weryha G; Enjalbert A; Barlier A
    Eur J Endocrinol; 2013 Apr; 168(4):533-41. PubMed ID: 23321498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent expression of aryl hydrocarbon receptor and CYP1A1 but not CYP1A1 MspI polymorphism is correlated with gastric cancers raised in Dalian, China.
    Ma JX; Zhang KL; Liu X; Ma YL; Pei LN; Zhu YF; Zhou L; Chen XY; Kong QY; Li H; Liu J
    Cancer Lett; 2006 Aug; 240(2):253-60. PubMed ID: 16337337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for AIP gene mutations in a Han Chinese pituitary adenoma cohort followed by LOH analysis.
    Cai F; Zhang YD; Zhao X; Yang YK; Ma SH; Dai CX; Liu XH; Yao Y; Feng M; Wei JJ; Xing B; Jiao YH; Wei ZQ; Yin ZM; Zhang B; Gu F; Wang RZ
    Eur J Endocrinol; 2013 Dec; 169(6):867-84. PubMed ID: 24050928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aryl hydrocarbon receptor interacting protein variants in sporadic pituitary adenomas.
    Yu R; Bonert V; Saporta I; Raffel LJ; Melmed S
    J Clin Endocrinol Metab; 2006 Dec; 91(12):5126-9. PubMed ID: 17018653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.